Amalgamated Bank’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
CAMG
ECM
RHJA
Amalgamated Bank's CLB Position: Q2 2026 in Review
Amalgamated Bank reduced its Core Laboratories (CLB) stake by 7.6% in Q2 2026, selling an estimated $14.6K and leaving 12,396 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #1604.
Amalgamated Bank first reported a position in CLB in Q2 2021 and has held it in 21 quarters since. The position peaked at $614K in Q2 2021. 84 funds tracked by Wall St. Rank hold CLB as of Q2 2026.
- Amalgamated Bank held 12,396 shares of Core Laboratories worth $144K as of Q2 2026.
- Amalgamated Bank sold 1,024 Core Laboratories shares in Q2 2026, an estimated $14.6K.
- Core Laboratories made up ﹤0.01% of Amalgamated Bank's portfolio in Q2 2026, its #1604 holding.
- Amalgamated Bank first reported a position in Core Laboratories in Q2 2021 and has held it in 21 quarters since.
- Amalgamated Bank's Core Laboratories position peaked at $614K in Q2 2021.
- 84 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.
Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.